Hit Discovery, Discovery Sciences, AstraZeneca R&D, Cambridge, UK.
Hit Discovery, Discovery Sciences, AstraZeneca R&D, Cambridge, UK.
SLAS Discov. 2024 Apr;29(3):100142. doi: 10.1016/j.slasd.2024.01.003. Epub 2024 Jan 24.
Covalent hits for drug discovery campaigns are neither fantastic beasts nor mythical creatures, they can be routinely identified through electrophile-first screening campaigns using a suite of different techniques. These include biophysical and biochemical methods, cellular approaches, and DNA-encoded libraries. Employing best practice, however, is critical to success. The purpose of this review is to look at state of the art covalent hit identification, how to identify hits from a covalent library and how to select compounds for medicinal chemistry programmes.
共价命中药物发现活动既不是奇异的野兽也不是神话般的生物,它们可以通过使用一系列不同技术的亲电试剂优先筛选活动来常规地识别。这些方法包括生物物理和生化方法、细胞方法和 DNA 编码文库。然而,采用最佳实践是成功的关键。本文的目的是探讨最新的共价命中鉴定技术,如何从共价文库中鉴定命中化合物以及如何选择化合物用于药物化学项目。